Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03078244
Other study ID # ACHT41
Secondary ID
Status Completed
Phase N/A
First received March 8, 2017
Last updated February 15, 2018
Start date November 2016
Est. completion date August 31, 2017

Study information

Verified date February 2018
Source George Clinical Pty Ltd
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Project aims to determine the number of individuals with treatment resistant hypertension and to define the characteristics of these patients and estimate disease frequency. The study will be a retrospective review of medical record data based upon deā€identified information and will require no patient contact.


Recruitment information / eligibility

Status Completed
Enrollment 1500
Est. completion date August 31, 2017
Est. primary completion date August 31, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- > = 18 years of age

- No known secondary cause of hypertension

- History of uncontrolled hypertension while using 3 or more anti-hypertensive agents

- Controlled blood pressure using 4 or more different anti-hypertensive agents

Exclusion Criteria:

Study Design


Related Conditions & MeSH terms


Intervention

Other:
N/A, observational study


Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
George Clinical Pty Ltd Actelion, The George Institute

Outcome

Type Measure Description Time frame Safety issue
Primary Number of adult subjects with treatment resistant hypertension one year
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03317951 - Investigation of a Novel Integrated Care Concept (NICC) for Patients Suffering From Chronic Cardiovascular Disease N/A